Research Article
FOXP3+ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF Agents
Table 2
Immunohistochemical study: baseline characteristics of IBD patients and controls.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IBD: inflammatory bowel disease; TNF: tumor necrosis factor; IBS: irritable bowel syndrome. |